fangxianuo / iStockphoto
28 June 2017Biotechnology
CRISPR in Europe: priority becomes just that at the EPO
On April 19, 2017 a preliminary (and non-binding) opinion was issued on the first of the oppositions to the Broad Institute’s granted European patents on CRISPR/Cas9 (European patent number EP 2 771 469).
